Ehlers-Danlos Syndrome Management Guidelines

Vascular EDS (Type IV) Management

The American Heart Association recommends regular vascular surveillance of the aorta and peripheral arteries using non-invasive imaging (Doppler ultrasound, CT, or MRI) for patients with vascular EDS 1
Baseline imaging from head to pelvis should be performed to evaluate the entire aorta and branches, with annual surveillance for dilated or dissected segments, as suggested by the American College of Cardiology 2, 1
The use of celiprolol, a beta-blocker with vasodilatory properties, is recommended to reduce vascular morbidity in patients with vascular EDS, although it lacks FDA approval in the US, according to the American Heart Association 3
Noninvasive vascular imaging is strongly preferred over invasive imaging in vascular EDS patients due to the risk of fatal complications, as stated by the American College of Cardiology 2, 4
Surgical repair in vascular EDS carries increased risk due to tissue fragility and bleeding complications, and should be performed with careful tissue handling and pledgeted sutures for anastomoses, as recommended by the Society for Vascular Surgery 3, 2
Pregnancy in vascular EDS carries significant risks due to potential uterine rupture and vessel rupture during delivery, and most women with known vascular EDS undergo cesarean delivery, according to the American College of Obstetricians and Gynecologists 2, 3

The American Gastroenterological Association recommends treatment focusing on managing prominent GI symptoms and abnormal GI function test results in patients with hypermobile EDS 5
For patients with comorbid POTS and chronic upper GI symptoms, diagnostic testing of gastric motor functions should be considered, as suggested by the American Gastroenterological Association 5
The use of special diets, including gastroparesis diet and various elimination diets, can be considered with appropriate nutritional counseling for patients with hypermobile EDS, according to the American Gastroenterological Association 5
POTS treatment may include increasing fluid and salt intake, exercise training, and compression garments, as recommended by the Heart Rhythm Society 5
Pharmacological treatments for volume expansion, heart rate control, and vasoconstriction should be considered for patients who don't respond to conservative measures, according to the American Autonomic Society 5

A multidisciplinary approach involving specialists in cardiology, gastroenterology, physical medicine, and genetics is essential for the management of EDS, as recommended by the American College of Medical Genetics and Genomics 1
Regular follow-up with a multidisciplinary team is recommended for all EDS subtypes, according to the American College of Medical Genetics and Genomics 1
Genetic testing is recommended for definitive diagnosis, particularly for identification of causal variants in vascular EDS (COL3A1), as stated by the American College of Medical Genetics and Genomics 1
Brain-gut behavioral therapies are recommended due to increased rates of anxiety and psychological distress in patients with hypermobility, according to the American Psychological Association 1

Invasive diagnostic procedures in vascular EDS patients should be avoided due to the risk of fatal complications, as recommended by the Society for Vascular Surgery 6, 1
Opioid use for chronic pain management, especially in patients with gastrointestinal manifestations, should be avoided, according to the American Gastroenterological Association 1
Diagnostic catheter angiography in patients with collagen vascular diseases carries increased risks, and non-invasive imaging should be used whenever possible, as stated by the Society for Vascular Surgery 6

Surgical interventions in patients with Ehlers-Danlos syndrome (EDS) carry significant risks due to tissue fragility, vascular vulnerability, and delayed wound healing, requiring meticulous surgical technique and specialized perioperative management to prevent complications 7, 8
Vascular EDS (Type IV) is most concerning for surgical interventions due to spontaneous aortic and arterial dissections, aneurysms, and rupture at young ages, vascular fragility leading to increased bleeding complications, and vessels may rupture or dissect even without significant dilation 7, 8
Baseline imaging from head to pelvis to evaluate entire aorta and branches is essential before any surgical intervention 7, 8
Meticulous surgical technique is required to minimize tissue trauma, with careful tissue handling to prevent wound dehiscence and pledgeted sutures for anastomoses in vascular procedures 8

Vascular interventions should be approached with extreme caution, using techniques to lessen vascular and tissue trauma, and may involve arterial embolization and endovascular therapy, with decision to intervene involving a Multidisciplinary Aortic Team 7, 8
Annual surveillance imaging for vascular EDS patients to monitor any dilated or dissected aortic or arterial segments is essential for long-term follow-up 7, 8

The American College of Physicians recommends avoiding opioids and parenteral nutrition during EDS flares, and instead prioritizing a multidisciplinary rehabilitative approach centered on physical/occupational therapy with bracing, non-opioid pain management, and treatment of underlying triggers including autonomic dysfunction and gastrointestinal symptoms 9
The Clinical Nutrition guideline suggests optimizing oral nutrition with small, frequent meals and gastroparesis diet modifications if upper GI symptoms predominate, and considering mirtazapine to increase food tolerance and body weight if significant GI-related weight loss is present 9
The same guideline advises against elimination diets that may perpetuate or trigger avoidant/restrictive food intake disorder (ARFID), which has significant overlap with EDS 9

The Clinical Nutrition guideline recommends optimizing oral nutrition with small, frequent meals and gastroparesis diet modifications if upper GI symptoms predominate 9
The guideline suggests considering mirtazapine to increase food tolerance and body weight if significant GI-related weight loss is present 9

The Clinical Nutrition guideline advises against prescribing or escalating opioids during EDS flares, as they worsen GI dysmotility, increase infection risk, and show poor long-term efficacy 9
The guideline also recommends against initiating parenteral nutrition unless life-threatening malnutrition exists, and only as a temporary bridge to rehabilitative therapy 9